等待开盘 11-18 09:30:00 美东时间
-0.200
-2.59%
今日重点评级关注:Citizens:维持Precigen"跑赢大市"评级,目标价从11美元升至12美元;Leerink Partners:维持Arcus Biosciences"跑赢大市"评级,目标价从46美元升至49美元
11-06 16:15
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $10 to $9.
11-05 07:12
今日重点评级关注:Canaccord Genuity:维持Generac Holdings"买入"评级,目标价从275美元升至375美元;巴克莱:维持Oscar Health"超配"评级,目标价从39美元升至49美元
09-18 16:18
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $10 to $9.
09-17 20:07
The latest update is out from AdaptHealth ( ($AHCO) ). AdaptHealth Corp. announ...
09-09 05:13
AdaptHealth (AHCO) said on Tuesday it appointed Harriss T. Currie as chief financial officer, effective Sept. 9. Currie will succeed Jason Clemens, who will assist with the transition through Oct. 1. ...
09-09 04:12
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Harriss T. Currie as its Chi...
09-09 04:00
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $10.
08-07 02:56
今日重点评级关注:HC Wainwright & Co.:维持Precigen"买入"评级,目标价从14美元升至18美元;HC Wainwright & Co.:维持Sophia Genetics"买入"评级,目标价从12美元升至14美元
08-06 11:36
AdaptHealth 2026财年第二季度营收7.403亿美元,同比增长12.7%,持续经营每股亏损1.07美元;合同转换成本和制造商提价压低利润,公司同步下调全年调整后EBITDA指引。
08-05 06:53